啟迪藥業(000590.SZ):中藥公司取得《藥品生產許可證》
格隆匯 3 月 22日丨啟迪藥業(000590.SZ)公佈,公司近日獲悉全資子公司古漢中藥有限公司(“中藥公司”)取得湖南省藥品監督管理局出具的《藥品生產許可證》。中藥公司實施的部分募集資金項目涉及的固體綜合製劑車間、綜合提取車間生產線通過了湖南省藥品監督管理局藥品GMP符合性現場檢查,並完成《藥品生產許可證》的變更備案。
此次《藥品生產許可證》變更備案是基於中藥公司實施的新建募投項目“固體制劑生產線技改項目”和“年產4億支古漢養生精口服液技改工程項目”涉及的固體綜合製劑車間【片劑、顆粒劑、丸劑(蜜丸、水蜜丸、水丸、濃縮丸)各一條生產線】、綜合提取車間(中藥提取生產線)及生產線通過了湖南省藥品監督管理局藥品GMP符合性現場檢查,有利於中藥公司綜合固體制劑車間和綜合提取車間工藝自動化、智能化水平及生產能力的提升,滿足市場需求,提高公司核心競爭力,對公司未來生產經營產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.